Latest Breaking News On - Secured note - Page 3 : comparemela.com

AgeX Therapeutics : New Financial Obligation - Form 8-K -Today at 04:49 pm

AgeX Therapeutics : New Financial Obligation - Form 8-K -Today at 04:49 pm
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesExchange commissionSecurities exchangeAgex therapeutics incSecurities exchange actSecurities actExchange actAgex therapeuticsDirect financial obligationOff balance sheet arrangementRestated secured convertible promissory notePrepayment dateSecured noteQuarterly reportPage interactive data file

Form SC 13D/A Accelerate Diagnostics, Filed by: SCHULER JACK W

Form SC 13D/A Accelerate Diagnostics, Filed by: SCHULER JACK W
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesState of illinoisLake forestJackw schulerExchange commissionJackw schuler livingDiagnostics incSchuler family foundationSecurities exchangeExchange agreementSecurities exchange actCusip numberTelephone numberReceive noticesRequires filingIndex found

AgeX Therapeutics Reports First Quarter 2023 Financial Results

ALAMEDA, Calif. (BUSINESS WIRE) AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.Balance Sheet InformationCash, cash equivalents, and restricted cash.

United statesAgex therapeutics incExchange commissionSerina therapeutics incAgex therapeuticsJuvenescence limitedSecured note lineRestated secured convertible promissory noteSecured noteTotal revenuesAccounting standards updateFinancial statements going concernQuarterly reportPrivate securities litigation reform actAnnual report

AgeX Therapeutics Reports First Quarter 2023 Financial Results

AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023. Balance. | May 12, 2023

United statesSerina therapeutics incExchange commissionAgex therapeutics incAgex therapeuticsJuvenescence limitedSecured note lineRestated secured convertible promissory noteSecured noteTotal revenuesAccounting standards updateFinancial statements going concernQuarterly reportPrivate securities litigation reform actAnnual reportNc stock exchange

AgeX Therapeutics Reports First Quarter 2023 Financial Results

AgeX Therapeutics Reports First Quarter 2023 Financial Results
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesSerina therapeutics incAgex therapeutics incExchange commissionJuvenescence limitedSecured note lineRestated secured convertible promissory noteSecured noteTotal revenuesAccounting standards updateFinancial statements going concernPrivate securities litigation reform actAgex therapeuticsAnnual reportAgex therapeutics stock